|Application Notes||Reconstitute in H20 to a concentration of 10,000IU/ml. The solution can then be diluted to other aqueous buffers.|
|Storage||-20°C; Lyophilized powder|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Human LeukinFeron is a combined preparation of natural cytokines involved in Cellular reactions elimination of pathogen (antigen). Treatment with LeukinFeron results in a reduced frequency of side effects caused by prospidine therapy. Human LeukinFeron in the combined therapy of Kaposi's sarcoma leads to a considerable improvement of the initially abnormal levels of immunocompetent and phagocytizing cells. A single dose of Human LeukinFeron is prodced from 1 million leukocytes isolated from donor's blood contains natural IFN-α 10,000IU and a complex of cytokines from the first phase of the immune response at their natural ratio: IL-6, IL-12, TNF-α, MIF and LIF. LF activates expression of HLA-Dr antigens on human immune effectors and improve immune recognition. LF provides the normalizing action on CD4/CD8 cells interaction and cytokine production by immunocompetent cells that is important for immunoreactivity. LF is applied for the treatment of many viral diseases, bacterial infections, including sepsis, Tuberculosis, chlamidial, mucoplasmic, herpetic infections and oncological diseases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.